NDC 63323-486-01 - Xylocaine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-486
- Requested NDC
- 63323-486-01
- Package NDCs from labels
- 63323-486-41, 63323-486-26, 63323-486-01, 63323-486-17, 63323-486-02, 63323-486-27, 63323-486-05, 63323-486-57
- Manufacturer
- Sportpharm LLC
- Effective date
- 2026-02-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Xylocaine - Sportpharm LLC | Sportpharm LLC | 2026-02-03 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine 2% (lidocaine HCl, injection, USP) 20mg/mL 50mL Multiple dose vial | Henry Schein, Inc. | 2025-11-07 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - ASCLEMED USA INC | ASCLEMED USA INC. DBA ENOVACHEM | ASCLEMED USA INC | ASCLEMED USA INC. DBA ENOVACHEM | 2025-06-21 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - Asclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM | Asclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM | 2025-05-31 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2025-04-22 | HUMAN PRESCRIPTION DRUG LABEL |
| XYLOCAINE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-27 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - General Injectables & Vaccines, Inc | General Injectables & Vaccines, Inc | 2022-12-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Fresenius Kabi USA, LLC | Fresenius Kabi Austria | Fresenius Kabi USA, LLC | Fresenius Kabi Austria | 2021-08-25 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Cardinal Health | Cardinal Health | 2019-09-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine | REMEDYREPACK INC. | 2019-04-30 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine | REMEDYREPACK INC. | 2019-02-12 | HUMAN PRESCRIPTION DRUG LABEL |
| General Surgery Kit - Centurion Medical Products | APP Pharmaceuticals, LLC | Centurion Medical Products | APP Pharmaceuticals, LLC | 2013-10-02 | MEDICAL DEVICE |
| Xylocaine - Centurion Medical Products | APP Pharmaceuticals, LLC | Centurion Medical Products | APP Pharmaceuticals, LLC | 2012-03-15 | MEDICAL DEVICE |
| Xylocaine | Physicians Total Care, Inc. | 2012-02-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-486-01 | Xylocaine | 10 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 10 | 13 | |
| 63323-486-02 | Xylocaine | 20 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 20 | 13 | |
| 63323-486-05 | Xylocaine | 50 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 50 | 13 | |
| 63323-486-17 | Xylocaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 | |
| 63323-486-27 | Xylocaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 | |
| 63323-486-57 | Xylocaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 | |
| 63323-486-26 | Xylocaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 7 | |
| 63323-486-41 | Xylocaine | 20 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 20 | 7 | |
| 63323-486-17 | Cardiovascular Procedure Kit | 10 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 10 mL | 20 mg in 1mL | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-486 | XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 13 | Current NDC, Legacy NDC, 6 package rows | 20210831_ba082c2f-64f4-419d-9c88-74f203316e17.zip |
| 63323-486 | XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 7 | Current NDC, Legacy NDC, 2 package rows | 20250515_4dd52202-8eef-4136-92dd-ada573b7cf74.zip |
| 63323-486 | CARDIOVASCULAR PROCEDURE KIT () KIT [CENTURION MEDICAL PRODUCTS] | 1 | Current NDC, Legacy NDC | 20120316_eed8f49f-3676-42ee-b86c-72f338818097.zip |
| 63323-486 | GENERAL SURGERY KIT () KIT [CENTURION MEDICAL PRODUCTS] | 1 | Current NDC, Legacy NDC | 20140327_168ff921-70aa-45fd-80a7-6447a6d5dfe8.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-486-01 | ML - Milliliter | 63323-486 | 53575e7c-ec30-491c-800d-e2f2e0aab918 | 1 | 2019-12-10 |
| 63323-486-02 | ML - Milliliter | 63323-486 | 8c00d362-7eff-4deb-bf43-53a9506aa19d | 1 | 2019-12-10 |
| 63323-486-05 | ML - Milliliter | 63323-486 | 049b2b3b-0d23-4b00-92d8-5e2643ad5117 | 1 | 2019-12-10 |
| 63323-486-17 | ML - Milliliter | 63323-486 | 06027263-d174-40ea-9f34-cde0ccedc0f0 | 1 | 2012-07-24 |
| 63323-486-26 | ML - Milliliter | 63323-486 | 348a52bc-c28e-4315-a03e-952005b530ba | 1 | 2016-09-02 |
| 63323-486-27 | ML - Milliliter | 63323-486 | a4f02f5d-1dcd-46e2-beca-2e3e86b55cf3 | 1 | 2012-07-24 |
| 63323-486-41 | ML - Milliliter | 63323-486 | cd3d5dcc-bbe6-424b-ae62-a3b6f1ecaa11 | 1 | 2025-11-13 |
| 63323-486-57 | ML - Milliliter | 63323-486 | b3d735e0-3978-4c1e-b496-40a57da89c1e | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Lifestar Pharma LLC | 8149138a-4106-4ae6-b7ad-f2559c7fa7e2 | 2024-08-13 | Warnings, Adverse reactions | 1737757 1737761 1737562 1737566 1737568 V13007Z41A |
| SANTO REMEDIO Alivio Pain Relieving Lavender Scent | LIDOCAINE HYDROCHLORIDE, MENTHOL | SANTO REMEDIO LLC | ab53c7f2-a768-4f36-89d6-e128a1a940c2 | 2024-08-05 | Warnings | V13007Z41A |
| Lidotral 5 Percent Roll On Gel | LIDOCAINE HYDROCHLORIDE | Puretek Corporation | 1c4c9ce5-f12d-9c47-e063-6294a90a0b3c | 2024-08-02 | Warnings, Adverse reactions | V13007Z41A |
| Lymph/Spleen Combo | ADENOSINUM TRIPHOSPHORICUM DINATRUM, APIS MELLIFICA, CASTANEA VESCA, CEANOTHUS AMERICANUS, CHININUM ARSENICOSUM, FERRUM METALLICUM, HELIANTHUS ANNUUS, JUNIPERUS COMMUNIS, LYMPH NODE (SUIS), MYOSOTIS ARVENSIS, NATRUM MURIATICUM, NATRUM SULPHURICUM, PHYTOLACCA DECANDRA, QUERCUS GLANDIUM SPIRITUS, SPLEEN (SUIS), SUCCINUM, THYMUS (SUIS), UBIDECARENONUM | Deseret Biologicals, Inc. | afce86e2-cbfa-44d4-b803-bc2ad5053357 | 2024-07-31 | Warnings | 451W47IQ8X |
| Lymph/Spleen Combo | JUNIPERUS COMMUNIS, QUERCUS GLANDIUM SPIRITUS, MYOSOTIS ARVENSIS, NATRUM SULPHURICUM, CEANOTHUS AMERICANUS, HELIANTHUS ANNUUS, NATRUM MURIATICUM, PHYTOLACCA DECANDRA, LYMPH NODE (SUIS), SPLEEN (SUIS), THYMUS (SUIS), CHININUM ARSENICOSUM, ADENOSINUM TRIPHOSPHORICUM DINATRUM, UBIDECARENONUM, FERRUM METALLICUM, SUCCINUM, CASTANEA VESCA, APIS MELLIFICA | Deseret Biologicals, Inc. | b55787b5-5e35-4342-8f00-ef202c353877 | 2024-07-31 | Warnings | 451W47IQ8X |
| Adrenapar | ARALIA QUINQUEFOLIA, AVENA SATIVA, GLANDULA SUPRARENALIS SUIS, HYPOTHALAMUS SUIS, ARSENICUM IODATUM, CALCAREA CARBONICA, IGNATIA AMARA, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, NUX VOMICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, ZINCUM METALLICUM | Energique, Inc. | 4080fcfb-7ef2-45f5-8c3b-592d3b66a120 | 2024-07-29 | Warnings | 451W47IQ8X |
| Lidotral 5% Gel | LIDOCAINE HCL | Puretek Corporation | 1e183af7-73d7-ff32-e063-6294a90a305b | 2024-07-25 | Warnings, Adverse reactions | V13007Z41A |
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 96117178-ebf0-1335-e053-2a95a90ac105 | 2024-07-24 | Warnings, Adverse reactions | V13007Z41A |
| Sodium Chloride | SODIUM CHLORIDE | Baxter Healthcare Corporation | f55bd888-5e01-474d-871b-24654c070178 | 2024-07-24 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium chloride | SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 83994d0c-8484-4505-abb5-8a384ed12288 | 2024-07-22 | Warnings, Adverse reactions | 451W47IQ8X |
| CVS Health Sunburn Relief Cooling | LIDOCAINE HYDROCHLORIDE | CVS PHARMACY | 1d6402ea-4201-27f9-e063-6294a90a43f5 | 2024-07-16 | Warnings | V13007Z41A |
| sodium chloride | SODIUM CHLORIDE | Becton Dickinson and Company | 8df7dcf6-8714-6caf-e053-2995a90ab8cc | 2024-07-15 | Warnings, Adverse reactions | 451W47IQ8X |
| Burn Relief | LIDOCAINE HCI 2.0% | Trifecta Pharmaceuticals USA, LLC. | e5e524cd-bb22-715f-e053-2995a90ab5d3 | 2024-07-12 | Warnings | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | NorthStar RxLLC | f065e6d2-b47e-433d-a1fb-f0449cd725f1 | 2024-07-05 | Warnings, Adverse reactions | 1737757 1737761 1737568 V13007Z41A |
| Solarcaine Burn Pain Relief 4oz | SOLARCAINE BURN PAIN RELIEF 4OZ | WellSpring Pharmaceutical Corporation | 2c0389db-ceb2-422b-9575-bdb8fe649a1e | 2024-06-26 | Warnings | V13007Z41A |
| ABREVA Rapid Pain Relief | GLYCERIN, LIDOCAINE | Haleon US Holdings LLC | 65bd242f-4c6a-436c-8ec0-7b2e0d73ed9d | 2024-06-20 | Warnings | V13007Z41A |
| LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 1b584ef0-3663-0d2a-e063-6394a90a1757 | 2024-06-20 | Warnings, Adverse reactions | 1737566 V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Asclemed USA, Inc. | 45416533-17a1-4757-b24e-b33d1ee57471 | 2024-06-20 | Warnings, Adverse reactions | 1010671 V13007Z41A |
| Neurozyl | LIDOCAINE HCL 4.12 % | PureTek Corporation | 1aca46c8-ff06-da0e-e063-6394a90a475f | 2024-06-13 | Warnings, Adverse reactions | V13007Z41A |
| Derma Pain Plus | CROTON TIGLIUM, NATRUM MURIATICUM, PLANTAGO MAJOR, RHUS TOXICODENDRON, SARSAPARILLA (SMILAX REGELII) | Peaceful Mountain, Inc. | 6fa79c31-e48e-4c83-baa2-96cef22cfee1 | 2024-06-13 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.